Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > TLT.WT Warrants

<< Previous

Bullboard Posts

Next >>

Post by RoseHeavenon Dec 03, 2021 9:33am

462 Views

Post# 34194152

TLT.WT Warrants

This warrant is expiring on August 22, 2024 and the excercise price is only $0.35. Given the potential of TLT, this warrant provides tremendous value and leverage to investors. People who do not have enough money to buy shares, can consider buying warrant, which is trading now @0.19 almost half the share price.

I own both shares and warrants (warrant 55%, stock 45%).

Thanks,

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec